Lifevantage Revenue 2010-2024 | LFVN

Lifevantage revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Lifevantage Annual Revenue
(Millions of US $)
2024 $200
2023 $213
2022 $206
2021 $220
2020 $233
2019 $226
2018 $203
2017 $199
2016 $207
2015 $190
2014 $214
2013 $208
2012 $126
2011 $39
2010 $11
2009 $0
Lifevantage Quarterly Revenue
(Millions of US $)
2024-12-31 $68
2024-09-30 $47
2024-06-30 $49
2024-03-31 $48
2023-12-31 $52
2023-09-30 $51
2023-06-30 $54
2023-03-31 $54
2022-12-31 $54
2022-09-30 $52
2022-06-30 $51
2022-03-31 $50
2021-12-31 $52
2021-09-30 $53
2021-06-30 $55
2021-03-31 $52
2020-12-31 $59
2020-09-30 $55
2020-06-30 $59
2020-03-31 $56
2019-12-31 $61
2019-09-30 $56
2019-06-30 $56
2019-03-31 $56
2018-12-31 $58
2018-09-30 $56
2018-06-30 $54
2018-03-31 $51
2017-12-31 $49
2017-09-30 $49
2017-06-30 $51
2017-03-31 $45
2016-12-31 $49
2016-09-30 $55
2016-06-30 $53
2016-03-31 $56
2015-12-31 $52
2015-09-30 $45
2015-06-30 $45
2015-03-31 $45
2014-12-31 $48
2014-09-30 $52
2014-06-30 $56
2014-03-31 $55
2013-12-31 $52
2013-09-30 $51
2013-06-30 $52
2013-03-31 $50
2012-12-31 $53
2012-09-30 $53
2012-06-30 $45
2012-03-31 $36
2011-12-31 $25
2011-09-30 $20
2011-06-30 $15
2011-03-31 $10
2010-12-31 $7
2010-09-30 $6
2010-06-30 $4
2010-03-31 $3
2009-12-31 $2
2009-09-30 $2
2009-06-30 $2
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.169B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $87.363B 23.91
Becton Dickinson (BDX) United States $57.057B 14.28
Cardinal Health (CAH) United States $32.542B 17.43
Straumann Holding AG (SAUHY) Switzerland $18.704B 0.00
Labcorp (LH) United States $18.166B 14.90
Cooper (COO) United States $15.901B 21.09
West Pharmaceutical Services (WST) United States $14.596B 29.91
Align Technology (ALGN) United States $12.549B 24.31
Henry Schein (HSIC) United States $7.930B 13.66
Merit Medical Systems (MMSI) United States $5.369B 26.12
Patterson (PDCO) United States $2.772B 15.98
DENTSPLY SIRONA (XRAY) United States $2.557B 7.68
CONMED (CNMD) United States $1.503B 11.68
STAAR Surgical (STAA) United States $0.833B 0.00
Pro-Dex (PDEX) United States $0.198B 30.26